|

NTB-928 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • TeneoSeven, Inc.1

Indications

  • Relapsed/Refractory Ovarian Carcinoma1
  • Cancer1

Lake Success, New York1 trial

Study of NTB-928 in R/R OC

START Northwell, LLC

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.